Boston Scientific (BSX) Cash from Operations (2009 - 2026)

Boston Scientific has disclosed Cash from Operations across 18 years of filings, most recently posting 348000000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 348000000.0, down 35.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 4341000000.0 (up 13.88% YoY), and the FY2025 annual result was 4534000000.0, up 31.99% from the prior year.
• Cash from Operations came in at 348000000.0 for Q1 2026 at Boston Scientific, down from 1364000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1456000000.0 in Q4 2024 to a low of 58000000.0 in Q1 2022.
• The 5-year median for Cash from Operations is 698000000.0 (2023), against an average of 726235294.12.
• Across the five-year window, Cash from Operations slumped 120.42% in 2022 and jumped 427.59% in 2023, its largest moves.
• Boston Scientific's Cash from Operations stood at 807000000.0 in 2022, then advanced by 18.59% to 957000000.0 in 2023, then jumped by 52.14% to 1456000000.0 in 2024, then fell by 6.32% to 1364000000.0 in 2025, then slumped by 74.49% to 348000000.0 in 2026.
• The last three Cash from Operations figures came in at 348000000.0 (Q1 2026), 1364000000.0 (Q4 2025), and 1343000000.0 (Q3 2025), per Business Quant data.